Guests will be treated to a BBQ complete with refreshments, music, and surprises. “We are greatly looking forward to personally meeting members of the Weedon community, introducing our local partners, gathering with public officials, and welcoming representatives of the press for an informative and entertaining afternoon at the CannaCanada/Weedonproject site”, Rob Gietl, CEO for MYM said.
The event will provide an excellent opportunity for guests, press, potential investors and shareholders, to meet face to face with the CannaCanada/Weedon project coordinators and see the site first hand.
For further information regarding the event, please contact Terry Brown at +1-855-696-2261 or via email at firstname.lastname@example.org
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).
ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on http://www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States“, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
MYM Investor Relations Contact:
Terry Brown – +1 (855) 696-2261
Click here to connect with MYM Nutraceuticals Inc (CSE:MYM) to receive an Investor Presentation.
Naturally Splendid (TSXV:NSP) is pleased to announce it has executed a definitive agreement with Prosnack Natural Foods Inc. (“Prosnack”) and iCream Capital Inc. (“iCream”) whereby Naturally Splendid has agreed to acquire all of the issued and outstanding shares of Prosnack. Prosnack is a Canadian company based in North Vancouver.
Under the terms of its agreement with Prosnack and iCream, Naturally Splendid has agreed to pay to iCream $200,000 in cash (the “Cash Consideration”), and to issue to iCream on closing 1,098,901 Naturally Splendid common shares (the “Share Consideration”). $69,000 of the Cash Consideration will be paid to iCream on closing and the $131,000 balance will be paid on or before December 29, 2017. Naturally Splendid may, at its option, pay all or any portion of the $131,000 remaining Cash Consideration by the issuance of additional Naturally Splendid common shares having a value of $212,875, based on the average closing price of Naturally Splendid’s common shares during the ten (10) trading days prior to December 29, 2017. The shares issuable to iCream will be subject to a four month hold period in accordance with applicable Canadian securities laws. As additional consideration, Naturally Splendid will, for a period of 5 years, make earn-out payments to iCream equal to 25% of the annual increases to Naturally Splendid’s retail, private labelling and co-pack sales over the preceding year. The aggregate total earn out payments that could be made to iCream will be capped at approximatey $1,200,000. Closing of the acquisition of Prosnack remains subject to certain conditions, including the approval of the TSX Venture Exchange.
Prosnack’s innovative “Elevate Me™” brand focuses on lifestyle and healthy meal replacement products that include energy bars and on-the-go oatmeals that are currently distributed throughout North America. The Elevate Me™ brand can be found in over 1,000 retail stores including major retailers such as Costco, Whole Foods, Choices, Save On Foods, Sobeys, London Drugs, Thrifty’s, Rexall and many more. A unique feature of Prosnack is its ongoing success strategy of private labelling for major retailers in North America and co-packing for other manufacturers globally. The combination of Elevate Me™ products and its private label clients is almost $8,000,000 CDN in sales over the past four years.
Naturally Splendid CEO, Dave Eto stated, “Our new relationship with Prosnack and its founders, Alan Maddox and Jim Pratt, continues our strategy to gain market share in the ‘healthy food sector’ retail markets. Not only will synergies benefit Naturally Splendid with enhanced and effective operating costs, leverage distribution and innovative products, but Alan’s relationships with retailers and co-packers and his business acumen strengthens both companies Canadian and US marketing and branding capabilities.”
Upon completion of the acquisition, Alan Maddox is expected to become Executive VP, Sales and Marketing for Naturally Splendid. Alan has built a successful career in the food industry spanning over 34 years. In addition to developing sales for Prosnack, Alan held the position of Director of International Sales for McCain Foods where he was responsible for overseeing sales development in over 70 countries around the world. As President of Sepp’s Food Group in the early 1990’s he was instrumental in developing the company into one of the leading natural organic frozen breakfast food manufacturers in North America, growing sales from $1,000,000 CDN to over $88,000,000 CDN annually.
Mr. Maddox stated, “This is an excellent environment for me to leverage my experience and contacts to combine distribution channels and move Elevate Me™ and products of Naturally Splendid to the next level – to be quicker and stronger throughout Canada, USA and internationally. With the fine brands of Prosnack complimenting the family of high quality products of NSE, I am very pleased to be part of the Naturally Splendid Family.”
Upon closing, Jim Pratt is expected to join Naturally Splendid’s Advisory Board. Naturally Splendid expects that his experience gained as a former investment banker on Bay Street in Toronto, and having directly overseen 15 acquisitions and divestitures with Sepp’s Food Group while serving as CFO and CEO, will be of great benefit. Mr. Pratt’s continuing involvement with the BC Food Processors Association as Chair establishes his credentials as a food sector leader and provides Naturally Splendid with additional insights into evolving markets and opportunities.
Mr. Pratt stated, “I’m excited to join Naturally Splendid in an advisory role. The Prosnack Natural Foods suite of products will add to the exciting story that NSE is developing in the consumer product and healthy food markets and I look forward to being part of that story.”
Alan and Jim partnered to purchase Prosnack Natural Foods, the makers of Elevate Me All-Natural Protein Bar in January 2013. This close working relationship that is expected to provide additional benefits to the overall growth strategies of Naturally Splendid.
As part of the acquisition, Naturally Splendid will take ownership of approximately $300,000 of automated manufacturing equipment in Prosnack’s manufacturing facility, located in North Vancouver. The facility complies with several certifications; SQF level 2, Kosher and Gluten free.
Mr. Eto added, “Prosnack’s persistent drive to innovate products for their clients is an excellent platform for the ingredient technology supplied by Naturally Splendid. I am very excited to have such excellent people join the Naturally Splendid team. A major component of Naturally Splendid’s future growth will be acquisitions within the food sector to help synergize both the bio-tech applications and consumer products in retail markets domestically and internationally. There are many hemp-based applications that are not yet realized and I want NSE to drive those opportunities.”
For more information about Prosnack, please visit their website at www.prosnack.com.
About Naturally Splendid Enterprises Ltd.
Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and non-psychoactive cannabinoid compounds in a broad spectrum of applications.
Naturally Splendid currently has four innovative divisions:
(1) BIOTECHNOLOGY – Focused on three major platforms:
(1) Proprietary HempOmega™ encapsulation.
(2) Extraction and formulation with Cannabidiol (CBD).
(3) Hemp and plant-based proteins.
- POS-BPC Facility – a 12,000-square-foot facility jointly owned by NSE 51%/ 49% POS Bio-Sciences, offers commercial-scale custom processing solutions for functional foods and natural health.
(2) CONSUMER PRODUCTS –
- NATERA® – brand of retail hemp and superfood products distributed throughout North America, Asia and Europe.
- Prosnack Natural Foods Inc. (Elevate Me™) – lifestyle brand of heathy meal replacement products distributed throughout North America.
- Chi Hemp Industries Incorporated (CHII) – e-commerce platform for natural and organic hemp products.
- PawsitiveFX® – topical pet care products.
- NATERA®CBD – retail hemp-based cannabinoid nutraceutical and cosmeceutical products distributed in Asia.
- NATERA®Skincare – brand of retail hemp based cosmeceutical products.
(3) NATERA® Ingredients – bulk ingredients including HempOmega™.
(4) Co-Packaging/Toll-Processing – packaging for house-brands (NATERA® and CHII) and third-party partners.
For more information e-mail email@example.com or call Investor Relations at 604-673-9573
On Behalf of the Board of Directors
Mr. Dave Eto
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to complete the acquisition of Prosnack, complete all or any of the proposed private placement financing, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Contact Information Naturally Splendid Enterprises Ltd. (NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt) #108-19100 Airport Way Pitt Meadows, BC, V3Y 0E2 Office: (604) 465-0548 Fax: (604) 465-1128 E-mail: firstname.lastname@example.org
Click here to connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.
Friday Night Inc. (the “Company”) (CSE:TGIF) (FRANKFURT:1QF) is pleased to announce that the Company has appointed Dr. Anthony R. Torres, MD to its board of advisors and would also like to provide an update on the genetics breeding program at the Company’s 91% owned subsidiary, Alternative Medicine Association, LC. (AMA).
NEW GENETIC STRAIN
Over the past several months, AMA has been cross breeding existing strains in hopes of creating an improved cannabis product. This time consuming and laborious process has resulted in a new product offering that only AMA will be able to provide.
One of AMA’s favorite prototype plants from the genetics program is a strain they have created and named “Naughty Cookies”. Over the last year and thousands of test plants later, AMA created the new strain by crossing the high-THC and popular ‘Girl Scout Cookies’ strain with the high-yielding ‘Juggernaut’ male. The buds are very frosty, aesthetically pleasing and dense with light purple coloration.
This week AMA received the test results for the first lot. The cannabinoid content was higher than any strain AMA had seen in the last 3 years, and the THC content came back as 34.9%. Most fortunately, AMA had the foresight to cultivate over 70 of these plants in anticipation of great results. These will be flowered during the next growing cycle and so far are yielding over 2 pounds per light of dried flower.
The creator of this strain and Director of Operations, Mr. Ben Horner said, “This gives us a competitive edge in a market which we now control. When new cultivators come on board, we will be the only producer with this strain. I feel it will inevitably become a favorite in Las Vegas.”
NEW ADVISOR TO THE COMPANY
Anthony R. Torres, M.D. with training at the National Institutes of Health, Yale University School of Medicine and the University of Utah, has considerable experience in the separation sciences of biological molecules. Anthony is widely published and has made a career not only in university research, but also in the biotechnology field including protein enrichment and advance separation processes. He is an inventor and owns several patents in the field. He is not new to the world of start-up companies and continues to be a pioneer in biotechnology. He also brings a deep understanding of the cannabis plant and its molecular structure.
Dr. Torres commented, “I am very interested in applying traditional laboratory processes to the rapidly developing field of molecular cannabis. I believe that there are many positive applications for the natural benefits of this plant in modern medicine and that it has the potential to help hundreds of thousands, perhaps even millions of people.”
About Friday Night Inc.
Friday Night Inc. is a Canadian public company, which owns and controls cannabis and hemp based assets in Las Vegas Nevada. The company owns 91% of Alternative Medicine Association, LC (AMA), a licensed medical and adult-use cannabis cultivation and production facility that produces its own line of unique cannabis-based products and manufactures other third-party brands. Infused MFG, also a 91% owned subsidiary, produces hemp-based, CBD products, thoughtfully crafted of high quality organic botanical ingredients. Friday Night Inc. is focused on strengthening and expanding these operations within and outside of the state.
For further information please contact:
Joe Bleackley, Corporate Communications
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the entering into a definitive agreement, the future exercise of the option regarding the vape lounge and the regulatory environment in Canada. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including failure to enter into a definitive agreement, inability to attract new customers in Nevada as a result of the license, the inability of the Company to take advantage of the license arrangement and various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. Friday Night undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law or the Canadian Securities Exchange.
Click here to connect with Friday Night Inc. to receive an Investor Presentation.
Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products announces it is proudly sponsoring the 50th Anniversary of IV International and XXIV Brazilian Congress of ABENEPI (Brazilian Association of Neurology and Child Psychiatry and Related Profession) August 9 – 12. The Company is sponsoring the symposium where one of the top Brazilian child neurologists will be speaking on the benefits of Cannabidiol to an audience of doctors, neurologists and psychologists.
Marcos Agramont CEO of Isodiol stated, “As we develop our footprint in Brazil and work through the process with Anvisa, sponsoring events like this will be very important for educating the market on the benefits of our Isoderm™ product. Over the last several months, we have been able to generate tremendous support for our products which we anticipate will continue as we move into additional countries.”
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived Cannabinoids, including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
Join Us On Facebook: https://www.facebook.com/Isodiol/
Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release.
Click here to connect with Isodiol International Inc. (CSE: ISOL) to receive an Investor Presentation.
Maple Leaf Green World (TSXV:MGW; OTCQB:MGWFF) announces the Company has submitted an abridgement application (the “Abridgment Application”) to Health Canada under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) for a license to produce and sell cannabis (the “License”). The Abridgement Application is an update and revision of the Company’s original application for the License pursuant to the Marihuana for Medical Purposes Regulation (“MMPR”) (the MMPR were succeeded by the ACMPR on August 24, 2016). The Abridgement Application provides an updated general description of the Company’s cannabis cultivation facility to be constructed in Telkwa, British Columbia (the “BC Site”), and outlines certain revisions to the Company’s original License application. The Abridgement Application includes the following main components:
- The floor plan of the 30,000 sq, ft. facility to be built at the BC Site with detailed layout of the security system and growing operation.
- Growing capacity of up to 5,500 KG a year based on projections of 50% for dry marijuana and 49% for Cannabis oil and 1% for other Cannabis product.
- Expected marketing of 84% of all products to patients and 16% to other licensed producers.
Health Canada is expected to review the Abridgement Application and may advise the Company of additional questions or comments. Upon Health Canadas satisfactory review of the Abridgement Application, it is expected that the Company will then be required to submit pictures, videos, and relevant documentation to Health Canada to demonstrate that the BC Site is built and operational, after which a License is then expected to be issued to the Company provided Health Canada finds the Company’s submissions compliant with ACMPR licensing requirements.
For further information regarding Maple Leaf Green World Inc., please visit www.mlgreenworld.com.
About Maple Leaf Green World Inc.
Maple Leaf is a public Canadian company that focuses on the cannabis industry in North America. The Company currently operates 3 cannabis projects in British Columbia, California, and Nevada. With over 10 years of extensive greenhouse management experience, it applies its eco-agriculture knowledge and cultivation technology to produce contaminant-free organic cannabis products. Maple Leafs long-term objective is to produce cannabis oil and export its products to approved countries.
This press release includes certain statements that may be deemed “forward-looking statements” within the meaning of applicable Canadian securities legislation. Specifically, this press release includes, but is not limited to, forward-looking statements with respect to the review of the Abridgement Application by Health Canada and the timing thereof, Health Canada’s review process for the License and anticipated approval timings, and the construction of the BC Site and the timelines thereof. Generally, forward-looking statements can be identified by the forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “projects”, “intends”, “anticipates”, or “does not anticipate”, or “believes”, or “variations of such words and phrases or state that certain actions, events or results “may”, “can”, “could”, “would”, “might”, or “will” be taken”, “occur” or “be achieved”. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause the actual results, level of activity, performance, or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the development and operation of the Companys projects, risks associated with general economic conditions, adverse industry events, marketing costs, loss of markets, future legislative and regulatory developments involving medical cannabis, inability to access sufficient capital from internal and external sources and/or inability to access sufficient capital on favourable terms, the medical cannabis industry in Canada and the jurisdictions where the Company operates generally, income tax and regulatory matters, competition, crop failure, currency and interest rate fluctuations, regulatory approvals including approvals from Health Canada of the Abridgement Application for the License, and those factors discussed in the sections relating to risk factors of our business filed in the Companys required securities filings on SEDAR. Although the Company has attempted to identify important factors that could cause results to differ materially from those contained in forward-looking statements, there may be other factors that cause results to be materially different from those anticipated, described, estimated, assessed or intended. There can be no assurance that any forward-looking statements will prove accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Maple Leaf Green World Inc.
Raymond Lai, Chairman, President & CEO
Big Reach Media, Inc. (Investor Relations)
Phone: (780) 632-6963
Mobile: (780) 964-4732
Click here to connect with Maple Leaf Green World (TSXV:MGW; OTCQB:MGWFF) to receive an Investor Presentation.
DOJA Cannabis Company (formerly SG Spirit Gold Inc.) (“DOJA” or the “Company“) is pleased to announce that it has completed its previously announced three-cornered amalgamation (the “Transaction“), pursuant to which it acquired all of the outstanding securities of Northern Lights Marijuana Company Ltd. (“Northern Lights“), a licensed Canadian cannabis producer. DOJA expects to commence trading on the Canadian Securities Exchange (“CSE“) under the symbol “DOJA” at market open on Wednesday, August 9, 2017.
DOJA™ is a premier cannabis lifestyle brand that will feature the highest quality handcrafted strains in Canada. DOJA’s state-of-the-art ACMPR licensed production facility is located in the heart of British Columbia’s picturesque Okanagan Valley. DOJA was founded by the proven entrepreneurial team that started SAXX Underwear®.
Trent Kitsch, CEO of DOJA commented, “Going public on the CSE is a great achievement for DOJA. With this larger stage, we now have the ability to reach a global investor base and we look forward to welcoming many new investors that share our vision for the future of cannabis to the DOJA team. As an authentic premium cannabis lifestyle brand, we have established deep roots locally and we are now extending out strong branches that will take the brand beyond the Canadian border. We are cannabis futurists – that believe cannabis is not what defines people, it is just a part of their lifestyle.”
Closing of the Transaction
In connection with the Closing, DOJA’s wholly-owned subsidiary amalgamated with Northern Lights under the provisions of the Business Corporations Act (British Columbia), with the amalgamated company being named “DOJA Cannabis Ltd.” and now being a wholly-owned subsidiary of DOJA. DOJA issued 1.8 common shares in the capital of the Company (each, a “DOJA Share“) for each Northern Lights share outstanding. Convertible securities of Northern Lights were exchanged, subject to adjustment, into similar convertible securities of DOJA.
After giving effect to the completion of the Transaction and the conversion, there are 58,752,962 Shares issued and outstanding (on an undiluted basis), with approximately 33% of the Shares (on an undiluted basis) held by insiders.
For further information concerning the Transaction readers are encouraged to review the Company’s listing statement that was filed on the SEDAR website at www.sedar.com on August 1, 2017.
New Board of Directors and Management Team
In connection with the Closing, the Company welcomes a new board of directors and management team. The Company will be led by Trent Kitsch, who has been appointed Chief Executive Officer and Chairman, and Ryan Foreman, who has been appointed as President and director. In addition, Patrick Brauckmann and Stewart Thornhill have been appointed as independent directors of the Company. Jeff Barber has been appointed Chief Financial Officer and director and Ria Kitsch has been appointed Vice-President. Each of Richard Ko, Richard Grayston and Mark Ferguson have resigned as directors and officers of the Company and DOJA thanks them for their service in bringing the Company to completion of its Transaction.
William Trent Kitsch of 3370 Neid Road, Kelowna, BC V1W 4H5, CEO and a director of pre-Amalgamation Northern Lights Company Limited and now CEO and a director of DOJA Cannabis Company Limited, held 4,153,472 Northern Lights Shares. Upon completion of the Amalgamation, Mr. Kitsch now beneficially owns and has control over 7,476,250 DOJA Shares representing 12.7% of the issued and outstanding DOJA Shares.
Ryan Forman 3984 16th Avenue W., Vancouver, BC V6R 3C8, President and a director of pre-Amalgamation Northern Lights Company Limited and now President and a director of DOJA Cannabis Company Limited, held 4,007,240 Northern Lights Shares. Upon completion of the Amalgamation, Mr. Foreman now beneficially owns and has control over 7,213,032 DOJA Shares representing 12.3% of the issued and outstanding DOJA Shares.
A copy of the early warning reports filed pursuant to National Instrument 62-103 The Early Warning System and Related Take Over Bids and Insider Reporting Issues can be found at www.sedar.com
ON BEHALF OF THE BOARD OF DIRECTORS
Chief Executive Officer and Chairman of the Board
The DOJA team also encourages readers to visit the website at www.doja.life to learn more about DOJA and to sign up for DOJA news updates.
This news release contains forward-looking statements and information that are based on the beliefs of management and reflect the Company’s current expectations. When used in this news release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. The forward-looking statements and information in this news release include information relating to the business plans of the DOJA, the listing and trading of the DOJA shares and the Transaction. Such statements and information reflect the current views of the Company.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.
The Canadian Securities Exchange, has not passed upon the merits of the Transaction and has not approved nor disapproved the contents of this news release.
SOURCE DOJA Cannabis Company Limited
Click here to connect with DOJA Cannabis Company to receive an Investor Presentation.